Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement
J B Petro, S M Rahman, D W Ballard, W N Khan, J B Petro, S M Rahman, D W Ballard, W N Khan
Abstract
Mutations in the gene encoding Bruton's tyrosine kinase (btk) cause the B cell deficiency diseases X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. In vivo and in vitro studies indicate that the BTK protein is essential for B cell survival, cell cycle progression, and proliferation in response to B cell antigen receptor (BCR) stimulation. BCR stimulation leads to the activation of transcription factor nuclear factor (NF)-kappaB, which in turn regulates genes controlling B cell growth. We now demonstrate that a null mutation in btk known to cause the xid phenotype prevents BCR-induced activation of NF-kappaB. This defect can be rescued by reconstitution with wild-type BTK. This mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that BTK couples IKK and NF-kappaB to the BCR. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.
Figures
References
- Campbell K.S. Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol. 1999;11:256–264.
- Aoki Y., Isselbacher K.J., Pillai S. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc. Natl. Acad. Sci. USA. 1994;91:10606–10609.
- de Weers M., Brouns G.S., Hinshelwood S., Kinnon C., Schuurman R.K., Hendriks R.W., Borst J. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 1994;269:23857–23860.
- Anderson J.S., Teutch M., Dong Z., Wortis H.H. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA. 1996;93:10966–10971.
- Solvason N., Wu W.W., Kabra N., Lund-Johansen F., Roncarolo M.G., Behrens T.W., Grillot D.A., Nunez G., Lees E., Howard M. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 1998;187:1081–1091.
- Takata M., Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J. Exp. Med. 1996;184:31–40.
- Fluckiger A.C., Li Z., Kato R.M., Wahl M.I., Ochs H.D., Longnecker R., Kinet J.P., Witte O.N., Scharenberg A.M., Rawlings D.J. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO (Eur. Mol. Biol. Organ.) J. 1998;17:1973–1985.
- Imboden J.B., Stobo J.D. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 1985;161:446–456.
- Berridge M.J. Inositol trisphosphate and calcium signalling. Nature. 1993;361:315–325.
- Bootman M.D., Berridge M.J. The elemental principles of calcium signaling. Cell. 1995;83:675–678.
- Conley M.E., Cooper M.D. Genetic basis of abnormal B cell development. Curr. Opin. Immunol. 1998;10:399–406.
- Rawlings D.J. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin. Immunol. 1999;91:243–253.
- Campana D., Farrant J., Inamdar N., Webster A.D., Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J. Immunol. 1990;145:1675–1680.
- Pearl E.R., Vogler L.B., Okos A.J., Crist W.M., Lawton A.R.D., Cooper M.D. B lymphocyte precursors in human bone marrowan analysis of normal individuals and patients with antibody-deficiency states. J. Immunol. 1978;120:1169–1175.
- Rawlings D.J., Saffran D.C., Tsukada S., Largaespada D.A., Grimaldi J.C., Cohen L., Mohr R.N., Bazan J.F., Howard M., Copeland N.G. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261:358–361.
- Thomas J.D., Sideras P., Smith C.I., Vorechovsky I., Chapman V., Paul W.E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 1993;261:355–358.
- Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A. Defective B cell development and function in Btk-deficient mice. Immunity. 1995;3:283–299.
- Kerner J.D., Appleby M.W., Mohr R.N., Chien S., Rawlings D.J., Maliszewski C.R., Witte O.N., Perlmutter R.M. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 1995;3:301–312.
- Scher I. The CBA/N mouse strainan experimental model illustrating the influence of the X-chromosome on immunity. Adv. Immunol. 1982;33:1–71.
- Brorson K., Brunswick M., Ezhevsky S., Wei D.G., Berg R., Scott D., Stein K.E. xid affects events leading to B cell cycle entry. J. Immunol. 1997;159:135–143.
- Forssell J., Nilsson A., Sideras P. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4. Scand. J. Immunol. 1999;49:155–161.
- Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA. 1999;96:9136–9141.
- Bendall H.H., Sikes M.L., Ballard D.W., Oltz E.M. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. Mol. Immunol. 1999;36:187–195.
- Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 1998;187:663–674.
- Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995;9:1965–1977.
- Baldwin A.S., Jr. The NF-kappa B and I kappa B proteinsnew discoveries and insights. Annu. Rev. Immunol. 1996;14:649–683.
- Zandi E., Karin M. Bridging the gapcomposition, regulation, and physiological function of the IkappaB kinase complex. Mol. Cell. Biol. 1999;19:4547–4551.
- Francis D.A., Sen R., Rice N., Rothstein T.L. Receptor-specific induction of NF-kappaB components in primary B cells. Int. Immunol. 1998;10:285–293.
- Liou H.C., Sha W.C., Scott M.L., Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 1994;14:5349–5359.
- Shaffer A.L., Peng A., Schlissel M.S. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cellsa model for kappa locus activation. Immunity. 1997;6:131–143.
- Brockman J.A., Scherer D.C., McKinsey T.A., Hall S.M., Qi X., Lee W.Y., Ballard D.W. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 1995;15:2809–2818.
- Ballard D.W., Walker W.H., Doerre S., Sista P., Molitor J.A., Dixon E.P., Peffer N.J., Hannink M., Greene W.C. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function. Cell. 1990;63:803–814.
- Inoue J.-I., Kerr L.D., Ransone L.J., Bengal E., Hunter T., Verma I.M. c-rel activates but v-rel suppresses transcription from kappaB sites. Proc. Natl. Acad. Sci. USA. 1991;88:3715–3719.
- Boothby M., Liou H.-C., Glimcher L.H. Differences in DNA sequence specifically among MHC class II X box binding proteins. J. Immunol. 1989;142:1005–1014.
- Chen C.L., Yull F.E., Kerr L.D. Differential serine phosphorylation regulates IkappaB-alpha inactivation. Biochem. Biophys. Res. Commun. 1999;257:798–806.
- Riviere I., Brose K., Mulligan R.C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA. 1995;92:6733–6737.
- Venkataraman L., Wang W., Sen R. Differential regulation of c-Rel translocation in activated B and T cells. J. Immunol. 1996;157:1149–1155.
- Miyamoto S., Schmitt M.J., Verma I.M. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA. 1994;91:5056–5060.
- DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., Karin M. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 1996;16:1295–1304.
- Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-kappa B/I kappa B familyintimate tales of association and dissociation. Genes Dev. 1995;9:2723–2735.
- Choi M.S., Holmann M., Atkins C.J., Klaus G.G. Expression of blc-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 1996;26:676–682.
- Bendall H.H., Scherer D.C., Edson C.R., Ballard D.W., Oltz E.M. Transcription factor NF-kappaB regulates inducible Oct-2 gene expression in precursor B lymphocytes. J. Biol. Chem. 1997;272:28826–28828.
- Corcoran L.M., Karvelas M., Nossal G.J., Ye Z.S., Jacks T., Baltimore D. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 1993;7:570–582.
- Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999;401:86–90.
- Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 1999;401:82–85.
- Craxton A., Jiang A., Kurosaki T., Clark E.A. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J. Biol. Chem. 1999;274:30644–30650.
- Sanz L., Sanchez P., Lallena M.J., Diaz-Meco M.T., Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO (Eur. Mol. Biol. Organ.) J. 1999;18:3044–3053.
- Lallena M.J., Diaz-Meco M.T., Bren G., Paya C.V., Moscat J. Activation of IkappaB kinase beta by protein kinase C isoforms. Mol. Cell. Biol. 1999;19:2180–2188.
- Trushin S.A., Pennington K.N., Algeciras-Schimnich A., Paya C.V. Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytes. J. Biol. Chem. 1999;274:22923–22931.
Source: PubMed